Development of a nested PCR assay for the detection of Fusarium solani DNA and its evaluation in the diagnosis of invasive fusariosis using an experimental mouse model

被引:15
作者
Ahmad, Suhail [1 ]
Khan, Zia U. [1 ]
Theyyathel, Ajmal M. [1 ]
机构
[1] Kuwait Univ, Fac Med, Dept Microbiol, Safat 13110, Kuwait
关键词
Fusarium solani; nested PCR; development; evaluation; experimental Fusarium infection; REAL-TIME PCR; BRONCHOALVEOLAR LAVAGE; IN-VITRO; ASPERGILLUS; GALACTOMANNAN; VORICONAZOLE; INFECTIONS; SERUM; (1-3)-BETA-D-GLUCAN; IDENTIFICATION;
D O I
10.1111/j.1439-0507.2008.01657.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
P>Fusarium infections are increasingly being encountered in immunocompromised patients. Fusarium solani accounts for nearly half of these infections. A specific nested PCR (nPCR) assay has been developed by using DNA isolated from several Fusarium species and other common fungi. Furthermore, DNA samples isolated from bronchoalveolar lavage (BAL) and serum samples from mice infected intravenously with F. solani conidia and sacrificed on every third day post infection were used for the evaluation of the established nPCR protocol. The lung homogenate, BAL and blood from infected animals were also cultured. The nPCR assay was specific for F. solani and detected 450 fg of DNA corresponding roughly to 11 F. solani cells. Cultures of lung homogenate of infected animals up to day 16 yielded F. solani with decreasing fungal load and were negative thereafter. The nPCR positivity in BAL was 100% concordant with lung tissue culture results. Although detection of F. solani DNA in serum was less sensitive than in BAL, it remained positive for longer duration. Our data from an experimental mouse model show that detection of DNA in BAL and to a lesser extent in serum by nPCR offers a sensitive and specific diagnostic approach to invasive F. solani infection.
引用
收藏
页码:40 / 47
页数:8
相关论文
共 35 条
  • [21] Contaminations occurring in fungal PCR assays
    Loeffler, J
    Hebart, I
    Bialek, R
    Hagmeyer, L
    Schmidt, D
    Serey, FP
    Hartmann, M
    Eucker, J
    Einsele, H
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (04) : 1200 - 1202
  • [22] Experimental pathogenicity of four opportunist Fusarium species in a murine model
    Mayayo, E
    Pujol, I
    Guarro, J
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 1999, 48 (04) : 363 - 366
  • [23] TAXONOMY, BIOLOGY, AND CLINICAL ASPECTS OF FUSARIUM SPECIES
    NELSON, PE
    DIGNANI, MC
    ANAISSIE, EJ
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 1994, 7 (04) : 479 - &
  • [24] Molecular identification of Fusarium species in onychomycoses
    Ninet, B
    Jan, I
    Bontems, O
    Léchenne,
    Jousson, O
    Lew, D
    Schrenzel, J
    Panizzon, RG
    Monod, M
    [J]. DERMATOLOGY, 2005, 210 (01) : 21 - 25
  • [25] Fusarium infection in hematopoietic stem cell transplant recipients
    Nucci, M
    Marr, KA
    Queiroz-Telles, F
    Martins, CA
    Trabasso, P
    Costa, S
    Voltarelli, JC
    Colombo, AL
    Imhof, A
    Pasquini, R
    Maiolino, A
    Souza, CA
    Anaissie, E
    [J]. CLINICAL INFECTIOUS DISEASES, 2004, 38 (09) : 1237 - 1242
  • [26] Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection
    Nucci, M
    Anaissie, EJ
    Queiroz-Telles, F
    Martins, CA
    Trabasso, P
    Solza, C
    Mangini, C
    Simoes, BP
    Colombo, AL
    Vaz, J
    Levy, CE
    Costa, S
    Moreira, VA
    Oliveira, JS
    Paraguay, N
    Duboc, G
    Voltarelli, JC
    Maiolino, A
    Pasquini, R
    Souza, CA
    [J]. CANCER, 2003, 98 (02) : 315 - 319
  • [27] Cutaneous infection by Fusarium species in healthy and Immunocompromised hosts:: Implications for diagnosis and management
    Nucci, M
    Anaissie, E
    [J]. CLINICAL INFECTIOUS DISEASES, 2002, 35 (08) : 909 - 920
  • [28] Fusarium Infections in Immunocompromised Patients
    Nucci, Marcio
    Anaissie, Elias
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 2007, 20 (04) : 695 - 704
  • [29] Emerging fungi
    Nucci, Marcio
    Anaissie, Elias
    [J]. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2006, 20 (03) : 563 - +
  • [30] Antifungal susceptibility testing: Practical aspects and current challenges
    Rex, JH
    Pfaller, MA
    Walsh, TJ
    Chaturvedi, V
    Espinel-Ingroff, A
    Ghannoum, MA
    Gosey, LL
    Odds, FC
    Rinaldi, MG
    Sheehan, DJ
    Warnock, DW
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 2001, 14 (04) : 643 - 658